Cleared Traditional

K173140 - VivaChek Ino Smart Blood Glucose Monito...

K173140 is the FDA 510(k) clearance for VivaChek Ino Smart Blood Glucose Monito... by Vivachek Laboratories, Inc.. It is a Class 2 Chemistry device (product code NBW) cleared through the Traditional 510(k) pathway after a 446-day FDA review.

K173140 · Vivachek Laboratories, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
446d
Days
Class 2
Risk

K173140 is an FDA 510(k) clearance for the VivaChek Ino Smart Blood Glucose Monitoring System, VivaChek Ino Sync Blood G.... Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Vivachek Laboratories, Inc. (Wilmington, US). The FDA issued a Cleared decision on December 19, 2018 after a review of 446 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Chemistry submissions.

View all Vivachek Laboratories, Inc. devices

Submission Details

510(k) Number K173140 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2017
Decision Date December 19, 2018
Days to Decision 446 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
358d slower than avg
Panel avg: 88d · This submission: 446d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 235
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K173140.
GlucoLeader Enhance Blood Glucose Monitoring System
K182428 · Hmd Biomedical, Inc. · May 2019
GLUCOCARD® W onyx Blood Glucose Monitoring System
K183306 · Arkray Factory, Inc. · Apr 2019
iHealth Wireless Smart Gluco-Monitoring System (iHealth Gluco+)
K181070 · Andon Health Co, Ltd. · Feb 2019
Accu-Chek Guide Me Blood Glucose Monitoring System
K181131 · Roche Diabetes Care · Dec 2018
POPS! one Blood Glucose Monitoring System
K181588 · Taidoc Technology Corporation · Nov 2018
Tyson Bio HS100 Blood Glucose Monitoring System, Tyson Bio HS100-B Blood Glucose Monitoring System
K182046 · Tyson Bioresearch, Inc. · Nov 2018